We are live on
!
Find out more
WP
Woodline Partners Portfolio holdings
AUM
$26.4B
1-Year Est. Return
44.85%
This Fund
S&P 500
This Quarter
Est. Return
+2.52%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$7.16B
AUM Growth
+$666M
(+10%)
Cap. Flow
+$831M
Cap. Flow
% of AUM
11.61%
Top 10 Holdings %
Top 10 Hldgs %
17.05%
Holding
983
New
189
Increased
207
Reduced
145
Closed
240
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$146M |
| 2 |
Gilead Sciences
GILD
|
+$116M |
| 3 |
Amazon
AMZN
|
+$86.4M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$84.7M |
| 5 |
Analog Devices
ADI
|
+$80M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$73.2M |
| 2 |
Palo Alto Networks
PANW
|
+$59.8M |
| 3 |
Alkermes
ALKS
|
+$55.3M |
| 4 |
Accenture
ACN
|
+$53.8M |
| 5 |
Johnson & Johnson
JNJ
|
+$53M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 36.05% |
| 2 | Technology | 29.2% |
| 3 | Financials | 8.76% |
| 4 | Industrials | 7.7% |
| 5 | Communication Services | 4.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Encompass Health
EHC
$11B
| $11.9M | 0.17% |
263,153
+199,082
| +311% | +$9.96M |
|
177
Mercado Libre
MELI
$95.7B
| $11.8M | 0.17% |
+14,312
| New | +$12.3M |
|
178
DexCom
DXCM
$32.8B
| $11.8M | 0.17% |
147,054
-11,359
| -7% | -$962K |
|
179
Comcast
CMCSA
$88.5B
| $11.8M | 0.17% |
+403,359
| New | +$15.1M |
|
180
Booz Allen Hamilton
BAH
$8.85B
| $11.8M | 0.17% |
127,919
-60,409
| -32% | -$5.73M |
|
|
ANSS
181
DELISTED
Ansys
ANSS
| $11.5M | 0.16% |
51,738
+1,862
| +4% | +$476K |
|
|
PRO
182
DELISTED
PROS Holdings
PRO
| $11.3M | 0.16% |
457,486
-57,818
| -11% | -$1.4M |
|
183
Penumbra
PEN
$12.8B
| $11.3M | 0.16% |
+59,508
| New | +$9.55M |
|
184
Acadia Healthcare
ACHC
$2.95B
| $11.2M | 0.16% |
143,020
+91,959
| +180% | +$7.35M |
|
|
VYGG
185
DELISTED
Vy Global Growth
VYGG
| $11.2M | 0.16% |
1,110,568
+875,414
| +372% | +$8.72M |
|
186
Revolution Medicines
RVMD
$41.1B
| $11.1M | 0.16% |
563,881
+300,082
| +114% | +$6.59M |
|
|
HMCO
187
DELISTED
HumanCo Acquisition Corp. Class A Common Stock
HMCO
| $11M | 0.15% |
1,104,421
| – | – |
|
188
Aclaris Therapeutics
ACRS
$835M
| $11M | 0.15% |
697,007
+75,450
| +12% | +$1.19M |
|
|
KALV
189
DELISTED
KalVista Pharmaceuticals
KALV
| $10.9M | 0.15% |
752,881
-334,002
| -31% | -$4.67M |
|
190
Microsoft
MSFT
$3.66T
| $10.8M | 0.15% |
46,339
-170,212
| -79% | -$44.9M |
|
|
PING
191
DELISTED
Ping Identity Holding Corp.
PING
| $10.7M | 0.15% |
+382,000
| New | +$9.48M |
|
|
EXAI
192
DELISTED
Exscientia Plc American Depositary Shares
EXAI
| $10.7M | 0.15% |
1,305,006
+1,035,457
| +384% | +$10.4M |
|
193
PMV Pharmaceuticals
PMVP
$62.4M
| $10.7M | 0.15% |
899,307
+429,424
| +91% | +$6.2M |
|
194
Arcutis Biotherapeutics
ARQT
$3.26B
| $10.5M | 0.15% |
+550,396
| New | +$12.5M |
|
|
TEN
195
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
| $10.5M | 0.15% |
602,528
+14,131
| +2% | +$266K |
|
|
DMYS
196
DELISTED
dMY Technology Group, Inc. VI
DMYS
| $9.96M | 0.14% |
1,000,000
| – | – |
|
197
DaVita
DVA
$14.6B
| $9.86M | 0.14% |
+119,089
| New | +$10.4M |
|
198
Immunovant
IMVT
$8.08B
| $9.85M | 0.14% |
1,764,290
+1,672,190
| +1,816% | +$8.17M |
|
199
Coty
COTY
$2.56B
| $9.84M | 0.14% |
1,557,536
-317,529
| -17% | -$2.4M |
|
|
DICE
200
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
| $9.81M | 0.14% |
483,744
-153,243
| -24% | -$2.79M |
|
Similar funds
PAM
TCIIS
UIM
VAI
Woodline Partners's Q3 2022 Portfolio in Review
As of Q3 2022, Woodline Partners held 983 positions worth $7.16B, up 10% from $6.49B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Woodline Partners deployed $831M of net new capital in Q3 2022, opening 189 new positions and adding to 207 existing holdings. Its largest new stake was Amazon: 683,398 shares worth $77.2M.
By sector, the portfolio is most concentrated in Healthcare at 36% of assets, up from 35% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Eli Lilly, an estimated $73.2M trimmed.
- Woodline Partners's largest Q3 2022 buy was Amazon: 683,398 shares worth $77.2M.
- Woodline Partners added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2022, an estimated $146M increase.
- Woodline Partners's biggest Q3 2022 reduction was Eli Lilly, cutting an estimated $73.2M.
- Woodline Partners fully exited Palo Alto Networks in Q3 2022, selling an estimated $59.8M.
- Woodline Partners's ten largest holdings make up 17% of its $7.16B portfolio in Q3 2022.
- Woodline Partners opened 189 new positions and closed 240 in Q3 2022.
- Woodline Partners's portfolio value rose 10% quarter-over-quarter to $7.16B.
Based on Woodline Partners's 13F filing for Q3 2022, filed 14 Nov 2022.